Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2025)

Jin Medical International has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $495357.0 for Q3 2025.

• Current Deferred Revenue for Q3 2025 came in at $495357.0, down 26.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $495357.0 (down 26.22% YoY), and the FY2025 annual result was $495357.0, down 26.22% from the prior year.
• Current Deferred Revenue came in at $495357.0 for Q3 2025 at Jin Medical International, up from -$303500.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $830305.0 in Q3 2022 to a low of -$303500.0 in Q1 2025.
• The 4-year median for Current Deferred Revenue is $546988.0 (2024), against an average of $417261.4.
• Across the five-year window, Current Deferred Revenue surged 463.65% in 2024 and tumbled 155.49% in 2025, its largest moves.
• Jin Medical International's Current Deferred Revenue stood at $830305.0 in 2022, then slumped by 85.65% to $119120.0 in 2023, then soared by 463.65% to $671414.0 in 2024, then fell by 26.22% to $495357.0 in 2025.
• The last three Current Deferred Revenue figures came in at $495357.0 (Q3 2025), -$303500.0 (Q1 2025), and $671414.0 (Q3 2024), per Business Quant data.